文献速递口腔修复与种植牙周病

种植体失败与种植体周围炎的风险因素:回顾性队列研究

Risk Factors for Implant Failure and Peri-Implantitis: A Retrospective Cohort Study.
PubMed 文献 · Clin Oral Implants Res · 2026-09-25

该回顾性队列研究分析264例患者共554枚种植体,评估早期失败、晚期失败和种植体周围炎的相关因素。早期失败与自报青霉素过敏及前牙区种植相关,晚期失败与高血压、既往植骨位点及骨水平种植体相关,种植体周围炎与牙周炎、多余粘接剂及PLCBL相关。

要点

  • 自报青霉素过敏和前牙区种植与早期种植体失败风险升高相关。
  • 高血压、既往植骨位点和骨水平种植体与晚期种植体失败风险升高相关。
  • 牙周炎、多余粘接剂和PLCBL与种植体周围炎风险升高相关。

核心结论

  • 种植体失败和种植体周围炎与不同的、可能可改变的患者及治疗相关因素相关,识别这些因素有助于筛选高风险患者和种植体。

主要发现

  • 累计种植体失败率为6.8%(早期3.4%;晚期3.4%),种植体周围炎发生率为7.6%。
  • 多变量分析中,自报青霉素过敏(OR=7.9;95%CI:2.7-23.7)和前牙区种植(OR=5.4;95%CI:2.0-14.0)与早期失败风险升高相关,使用抗高血压药物(OR=0.26;95%CI:0.08-0.91)与风险降低相关(p<0.05)。
  • 晚期失败与高血压(HR=2.1;95%CI:1.3-3.3)、既往植骨位点(HR=1.4;95%CI:1.0-1.9)和骨水平种植体(HR=10.4;95%CI:5.5-19.5)相关;在聚类稳健敏感性分析中,骨水平种植体与晚期失败的关联减弱但仍显著(HR=3.38;95%CI:1.96-5.84)。
  • 种植体周围炎与牙周炎(HR=3.6;95%CI:1.89-6.97)、多余粘接剂(HR=2.7;95%CI:1.25-5.88)和PLCBL(HR=2.1;95%CI:1.09-4.13)相关(p<0.05)。

临床怎么用

  • 对自报青霉素过敏、前牙区种植、高血压、既往植骨位点、骨水平种植体、牙周炎、多余粘接剂或PLCBL的患者/种植体,应加强风险评估和监测。

局限性

  • 稳健性分析总体上支持所识别关联的方向,但部分效应估计值有所减弱。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This retrospective cohort study evaluated patient-, implant-, site-, procedural-, biological-, and prosthesis/mechanics-related factors associated with early and late implant failure and peri-implantitis. MATERIAL AND METHODS: Electronic health record data from a university center were analyzed. Forty patient-, implant/site-, biologic-, and prosthesis-related variables were evaluated in relation to early failure, late failure, and peri-implantitis. Bivariate and survival analyses were performed, followed by mixed-effects regression models appropriate to each outcome. Robustness was assessed via clustered bootstrap resampling, penalized regression, and sensitivity analyses. RESULTS: A total of 264 patients and 554 implants were assessed. Cumulative implant failure was 6.8% (3.4% early; 3.4% late), and peri-implantitis incidence was 7.6%. In multivariable analyses, self-reported penicillin allergy (OR = 7.9; 95% CI: 2.7-23.7) and anterior implant location (OR = 5.4; 95% CI: 2.0-14.0) were associated with higher odds of early implant failure, whereas antihypertensive medication use (OR = 0.26; 95% CI:0.08-0.91) was associated with lower odds (p < 0.05). Late implant failure was associated with hypertension (HR = 2.1; 95% CI: 1.3-3.3), previously grafted sites (HR = 1.4; 95% CI:1.0-1.9), and bone-level implants (HR = 10.4; 95% CI: 5.5-19.5). In cluster-robust sensitivity analysis, the association between bone-level implants and late implant failure was attenuated but remained significant (HR = 3.38; 95% CI: 1.96-5.84). Peri-implantitis was associated with periodontitis (HR = 3.6; 95% CI: 1.89-6.97), excess cement (HR = 2.7; 95% CI: 1.25-5.88), and PLCBL (HR = 2.1; 95% CI: 1.09-4.13) (p < 0.05). Robustness analyses generally supported the direction of the identified associations, although some effect estimates were attenuated. CONCLUSIONS: Implant failure and peri-implantitis are associated with distinct, potentially modifiable patient- and treatment-related factors. Recognition of these factors may help identify patients and implants at increased risk of adverse outcomes.

来源:Clin Oral Implants Res,查看原文。版权归原作者所有。

引用

  1. Vilela N, Gurgel BCV, da Silva HDP, et al. Risk Factors for Implant Failure and Peri-Implantitis: A Retrospective Cohort Study. Clin Oral Implants Res. 2026. PMID: 42791664. doi:10.1111/clr.70181

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。